Search Results - "OSAKA, TAKAFUMI"

Refine Results
  1. 1
  2. 2

    The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes by Hashimoto, Yoshitaka, Osaka, Takafumi, Fukuda, Takuya, Tanaka, Muhei, Yamazaki, Masahiro, Fukui, Michiaki

    Published in Endocrine Journal (2016)
    “…Recent cross-sectional studies revealed that sarcopenia is associated with non-alcoholic fatty liver disease (NAFLD) in general population. However, it remains…”
    Get full text
    Journal Article
  3. 3

    Intake of sucrose affects gut dysbiosis in patients with type 2 diabetes by Hashimoto, Yoshitaka, Hamaguchi, Masahide, Kaji, Ayumi, Sakai, Ryosuke, Osaka, Takafumi, Inoue, Ryo, Kashiwagi, Saori, Mizushima, Katsura, Uchiyama, Kazuhiko, Takagi, Tomohisa, Naito, Yuji, Fukui, Michiaki

    Published in Journal of diabetes investigation (01-11-2020)
    “…Aims/Introduction Gut dysbiosis is generally associated with type 2 diabetes mellitus. However, the effect of habitual dietary intake on gut dysbiosis in…”
    Get full text
    Journal Article
  4. 4

    miR-23b-3p acts as a counter-response against skeletal muscle atrophy by Okamura, Takuro, Hashimoto, Yoshitaka, Osaka, Takafumi, Senmaru, Takafumi, Fukuda, Takuya, Hamaguchi, Masahide, Fukui, Michiaki

    Published in Journal of endocrinology (01-03-2020)
    “…To investigate the role of microRNA (miRNA) in muscle atrophy, we performed microarray analysis of miRNA expression in skeletal muscles of Sham, orchiectomized…”
    Get full text
    Journal Article
  5. 5

    The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1 by Okamura, Takuro, Hashimoto, Yoshitaka, Osaka, Takafumi, Fukuda, Takuya, Hamaguchi, Masahide, Fukui, Michiaki

    “…We investigated the effect of the sodium glucose cotransporter-2 inhibitor (SGLT-2i) luseogliflozin on skeletal muscle. Eight-week-old mice were fed a standard…”
    Get full text
    Journal Article
  6. 6

    Favorable Appendicular Skeletal Muscle Mass Changes in Older Patients With Type 2 Diabetes Receiving GLP-1 Receptor Agonist and Basal Insulin Co-Therapy by Osaka, Takafumi, Hamaguchi, Masahide, Fukui, Michiaki

    “…Background And Aims: Maintaining appendicular skeletal muscle mass is important for maintaining the quality of life of elderly patients with type 2 diabetes…”
    Get full text
    Journal Article
  7. 7

    Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index by Nishida, Kensuke, Hashimoto, Yoshitaka, Kaji, Ayumi, Okamura, Takuro, Sakai, Ryousuke, Kitagawa, Noriyuki, Osaka, Takafumi, Hamaguchi, Masahide, Fukui, Michiaki

    Published in Endocrine Journal (01-01-2020)
    “…We have previously reported that the creatinine (Cre) to cystatin C (CysC) ratio is associated with height-adjusted skeletal muscle mass index (SMI). However,…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Effect of Teriparatide on Bone Mineral Density and Trabecular Bone Score in Type 2 Diabetic Patients with Osteoporosis: A Retrospective Cohort Study by Munekawa, Chihiro, Hashimoto, Yoshitaka, Kitagawa, Noriyuki, Osaka, Takafumi, Hamaguchi, Masahide, Fukui, Michiaki

    Published in Medicina (Kaunas, Lithuania) (26-03-2022)
    “…The BMDs of the lumbar spine, whole femur, and femoral neck and TBS were measured. Change in BMD or TBS was defined as the BMD or TBS at follow-up, performed 1…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Nonalcoholic fatty liver disease remission in men through regular exercise by Osaka, Takafumi, Hashimoto, Yoshitaka, Hamaguchi, Masahide, Kojima, Takao, Obora, Akihiro, Fukui, Michiaki

    “…Recent cross-sectional and randomized controlled studies of small sample sizes revealed that regular exercise is effective for improving nonalcoholic fatty…”
    Get full text
    Journal Article
  15. 15

    Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study by Kitae, Aya, Ushigome, Emi, Hashimoto, Yoshitaka, Majima, Saori, Senmaru, Takafumi, Osaka, Takafumi, Okada, Hiroshi, Hamaguchi, Masahide, Asano, Mai, Yamazaki, Masahiro, Fukui, Michiaki

    Published in Journal of diabetes investigation (01-05-2021)
    “…Aims/Introduction Postprandial hypotension (PPH) refers to a decrease in systolic blood pressure by ≥20 or to <90 mmHg from baseline ≥100 mmHg within 2 h of a…”
    Get full text
    Journal Article
  16. 16
  17. 17

    A Pilot Study on the Effect of Anti-Thrombopoietin Antibody on Platelet Count in Patients with Type 2 Diabetes by Fukuda, Takuya, Hamaguchi, Masahide, Osaka, Takafumi, Hashimoto, Yoshitaka, Ushigome, Emi, Asano, Mai, Yamazaki, Masahiro, Fukuda, Eriko, Yamaguchi, Kei, Ogawa, Koji, Goshima, Naoki, Fukui, Michiaki

    Published in Molecules (Basel, Switzerland) (04-04-2020)
    “…Thrombopoietin (THPO) is a circulatory cytokine that plays an important role in platelet production. The presence of anti-THPO antibody relates to…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Association between Hemoglobin Concentration and the Progression or Development of Albuminuria in Diabetic Kidney Disease by Okada, Hiroshi, Hasegawa, Goji, Tanaka, Muhei, Osaka, Takafumi, Shiotsu, Yayoi, Narumiya, Hiromichi, Inoue, Mamoru, Nakano, Koji, Nakamura, Naoto, Fukui, Michiaki

    Published in PloS one (29-05-2015)
    “…Anemia, which might contribute to pathogenesis of kidney dysfunction, is a common finding in patients with type 2 diabetes. The aim of this study was to…”
    Get full text
    Journal Article
  20. 20